CoLucid Pharmaceuticals to Present Corporate Overview at the Stifel 2015 Healthcare Conference
CAMBRIDGE, Mass., Nov. 12, 2015 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD) today announced that Thomas Mathers, Chief Executive Officer, will present a corporate overview at the Stifel 2015 Healthcare Conference.
| Stifel 2015 Healthcare Conference | |
| Date: | Wednesday, November 18, 2015 |
| Time: | 8:00am Eastern Time |
| Location: | Hubbard Room, The New York Palace Hotel |
| Webcast: | http://www.veracast.com/webcasts/stifel/healthcare2015/05201687339.cfm |
About CoLucid Pharmaceuticals, Inc.
CoLucid was founded in 2005 and is developing oral lasmiditan for the acute treatment of migraine headaches in adults and intravenous lasmiditan for the acute treatment of unspecified headache pain in adults in emergency room and other urgent care settings.
CONTACT: Thomas Mathers
Chief Executive Officer
CoLucid Pharmaceuticals, Inc.
(781) 365-2596
Hans Vitzthum
Managing Director
LifeSci Advisors, LLC.
(212) 915-2568
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
